IRIS Accounts Production v26.1.0.640 11897002 Board of Directors 1.4.25 31.3.26 31.3.26 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh118970022025-03-31118970022026-03-31118970022025-04-012026-03-31118970022024-03-31118970022024-04-012025-03-31118970022025-03-3111897002ns15:EnglandWales2025-04-012026-03-3111897002ns14:PoundSterling2025-04-012026-03-3111897002ns10:Director12025-04-012026-03-3111897002ns10:PrivateLimitedCompanyLtd2025-04-012026-03-3111897002ns10:Micro-entities2025-04-012026-03-3111897002ns10:AuditExemptWithAccountantsReport2025-04-012026-03-3111897002ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-3111897002ns10:FullAccounts2025-04-012026-03-3111897002ns5:CurrentFinancialInstruments2026-03-3111897002ns5:CurrentFinancialInstruments2025-03-3111897002ns10:RegisteredOffice2025-04-012026-03-3111897002ns10:Director112025-03-3111897002ns10:Director112024-03-3111897002ns10:Director112025-04-012026-03-3111897002ns10:Director112024-04-012025-03-3111897002ns10:Director112026-03-3111897002ns10:Director112025-03-3111897002ns10:Director32025-04-012026-03-3111897002ns10:Director332025-03-3111897002ns10:Director332024-03-3111897002ns10:Director332025-04-012026-03-3111897002ns10:Director332024-04-012025-03-3111897002ns10:Director332026-03-3111897002ns10:Director332025-03-3111897002ns10:Director22025-04-012026-03-31118970022ns10:Director22025-03-31118970022ns10:Director22024-03-31118970022ns10:Director22025-04-012026-03-31118970022ns10:Director22024-04-012025-03-31118970022ns10:Director22026-03-31118970022ns10:Director22025-03-31
REGISTERED NUMBER: 11897002 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026

FOR

MEDLINK SOLUTIONS LTD

MEDLINK SOLUTIONS LTD (REGISTERED NUMBER: 11897002)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026










Page

Report of the Accountants 1

Balance Sheet 2


MEDLINK SOLUTIONS LTD

REPORT OF THE ACCOUNTANTS TO THE DIRECTORS OF
MEDLINK SOLUTIONS LTD


The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement is not required to be filed with the Registrar of Companies.

As described on the Balance Sheet you are responsible for the preparation of the financial statements for the year ended 31 March 2026 set out on pages three to five and you consider that the company is exempt from an audit.

In accordance with your instructions, we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.






Workwell People Solutions Limited
4th Floor
Radius House
51 Clarendon Road
Watford
Hertfordshire
WD17 1HP


Date: .............................................

MEDLINK SOLUTIONS LTD (REGISTERED NUMBER: 11897002)

BALANCE SHEET
31 MARCH 2026

2026 2025
£    £    £    £   
Fixed assets 22,252 24,353

Current assets 73,399 142,878

Creditors
Amounts falling due within one year (17,009 ) (39,084 )
Net current assets 56,390 103,794
Total assets less current liabilities 78,642 128,147

Capital and reserves 78,642 128,147

Notes to the financial statements

1. Statutory information

Medlink Solutions Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 11897002

Registered office: FAO Workwell Accountancy
Ground Floor East - Hyde
38 Clarendon Road
Watford
Hertfordshire
WD17 1JW

2. Average number of employees

The average number of employees during the year was 4 (2025 - 4 ) .

MEDLINK SOLUTIONS LTD (REGISTERED NUMBER: 11897002)

BALANCE SHEET - continued
31 MARCH 2026

Notes to the financial statements

3. Directors' advances, credits and guarantees

The following advances and credits to directors subsisted during the years ended 31 March 2026 and 31 March 2025:

2026 2025
£    £   
Dr M Widgery
Balance outstanding at start of year 9,955 (224 )
Amounts advanced 4,871 12,423
Amounts repaid (15,130 ) (2,244 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (304 ) 9,955

Mr G J Widgery
Balance outstanding at start of year - (799 )
Amounts advanced 12,414 2,082
Amounts repaid (2,414 ) (1,283 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 10,000 -

Dr J L Kemper
Balance outstanding at start of year (1,893 ) -
Amounts advanced 22,544 25,870
Amounts repaid (20,651 ) (27,763 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - (1,893 )



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MEDLINK SOLUTIONS LTD (REGISTERED NUMBER: 11897002)

BALANCE SHEET - continued
31 MARCH 2026


The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 3 August 2026 and were signed on its behalf by:





Dr M Widgery - Director